Keyphrases
Medicare
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Low-income Subsidy
100%
Anticancer Treatment
100%
Treatment Uptake
100%
Out-of-pocket Expenditure
25%
Orally Administered
10%
Confidence Interval
10%
Older Adults
5%
Reduced Time
5%
Low-income
5%
Subsidies
5%
Anticancer Drugs
5%
Medicare Part D
5%
Medicare Data
5%
Non-small Cell Lung Cancer Patients
5%
Surveillance Epidemiology
5%
Statistical Test
5%
Negative Control
5%
Treatment Use
5%
Propensity Score
5%
Supplemental Insurance
5%
Subsidy Program
5%
Time to Initiation
5%
Barriers to Treatment
5%
Uptake Time
5%
Medication Uptake
5%
Cox Proportional Hazards Regression
5%
Medicine and Dentistry
Health Care Cost
100%
Medicare
100%
Lung Cancer
100%
Non Small Cell Lung Cancer
75%
Drug Therapy
50%
Anticarcinogen
25%
Proportional Hazards Model
25%
Surveillance, Epidemiology, and End Results
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Lung Cancer
100%
Anticarcinogen
33%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Statistical Test
25%